...
首页> 外文期刊>Analytical Biochemistry: An International Journal of Analytical and Preparative Methods >Identification and comparative oridonin metabolism in different species liver microsomes by using UPLC-Triple-TOF-MS/MS and PCA
【24h】

Identification and comparative oridonin metabolism in different species liver microsomes by using UPLC-Triple-TOF-MS/MS and PCA

机译:使用UPLC-Triple-TOF-MS / MS和PCA鉴定和比较不同物种肝微粒体中的冬凌草甲素代谢

获取原文
获取原文并翻译 | 示例
           

摘要

Oridonin (ORI) is an active natural ent-kaurene diterpenoid ingredient with notable anti-cancer and anti inflammation activities. Currently, a strategy was developed to identify metabolites and to assess the metabolic profiles of ORI in vitro using ultra-high-performance liquid chromatography-Triple/time-of-flight mass spectrometry (UPLC-Triple-TOF-MS/MS). Meanwhile, the metabolism differences of ORI in the liver microsomes of four different species were investigated using a principal component analysis (PCA) based on the metabolite absolute peak area values as the variables. Based on the proposed methods, 27 metabolites were structurally characterized. The results indicate that ORI is universally metabolized in vitro, and the metabolic pathway mainly includes dehydration, hydroxylation, di-hydroxylation, hydrogenation, decarboxylation, and ketone formation. Overall, there are obvious inter species differences in types and amounts of ORI metabolites in the four species. These results will provide basic data for future pharmacological and toxicological studies of ORI and for other ent-kauranes diterpenoids. Meanwhile, studying the ORI metabolic differences helps to select the proper animal model for further pharmacology and toxicological assessment. (C) 2016 Elsevier Inc. All rights reserved.
机译:冬凌草甲素(ORI)是一种有效的天然ENT-月桂烯二萜类成分,具有显着的抗癌和抗炎活性。当前,已开发了一种策略,可使用超高效液相色谱-三重/飞行时间质谱(UPLC-Triple-TOF-MS / MS)在体外鉴定代谢产物并评估ORI的代谢特征。同时,基于主要代谢物绝对峰面积值作为变量,使用主成分分析(PCA)研究了四种不同物种肝微粒体中ORI的代谢差异。基于提出的方法,对27种代谢物进行了结构表征。结果表明,ORI在体外普遍代谢,其代谢途径主要包括脱水,羟基化,二羟基化,氢化,脱羧和酮形成。总体而言,在这四个物种中,ORI代谢物的类型和数量之间存在明显的物种间差异。这些结果将为今后ORI的药理学和毒理学研究以及其他ENT-KAURANES二萜类化合物提供基础数据。同时,研究ORI代谢差异有助于选择合适的动物模型,以进行进一步的药理和毒理学评估。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号